Search Results - "V. Bazhin, Alexandr"

Refine Results
  1. 1

    Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy by Yang, Yuhui, Karakhanova, Svetlana, Hartwig, Werner, D'Haese, Jan G., Philippov, Pavel P., Werner, Jens, Bazhin, Alexandr V.

    Published in Journal of cellular physiology (01-12-2016)
    “…Mitochondria are indispensable for energy metabolism, apoptosis regulation, and cell signaling. Mitochondria in malignant cells differ structurally and…”
    Get full text
    Journal Article
  2. 2

    Reactive oxygen species and colorectal cancer by Lin, Sisi, Li, Yongyu, Zamyatnin, Andrey A., Werner, Jens, Bazhin, Alexandr V.

    Published in Journal of cellular physiology (01-07-2018)
    “…Colorectal cancer (CRC) has become the fourth leading cause of cancer‐related death in the worldwide. It is urgent to find more effective therapeutic…”
    Get full text
    Journal Article
  3. 3

    The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases by An, Lingxuan, Wirth, Ulrich, Koch, Dominik, Schirren, Malte, Drefs, Moritz, Koliogiannis, Dionysios, Nieß, Hanno, Andrassy, Joachim, Guba, Markus, Bazhin, Alexandr V., Werner, Jens, Kühn, Florian

    Published in Journal of gastrointestinal surgery (01-03-2022)
    “…Background Hepatosteatosis is the earliest stage in the pathogenesis of nonalcoholic fatty (NAFLD) and alcoholic liver disease (ALD). As NAFLD is affecting…”
    Get full text
    Journal Article
  4. 4

    Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling by Bazhin, Alexandr V, von Ahn, Katharina, Fritz, Jasmin, Werner, Jens, Karakhanova, Svetlana

    Published in Frontiers in immunology (27-09-2018)
    “…Interferon-α (IFNα) has one of the longest histories of use amongst cytokines in clinical oncology and has been applied for the treatment of many types of…”
    Get full text
    Journal Article
  5. 5

    Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer by Shevchenko, Ivan, Bazhin, Alexandr V

    Published in Frontiers in immunology (07-08-2018)
    “…Novel therapies targeting immune checkpoint molecules have redefined the treatment of cancer at advanced stages and brought hope to millions of patients…”
    Get full text
    Journal Article
  6. 6

    The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies by Soltani, Mojdeh, Zhao, Yue, Xia, Zhijia, Ganjalikhani Hakemi, Mazdak, Bazhin, Alexandr V.

    Published in Frontiers in oncology (10-11-2021)
    “…Despite recent advancements in the treatment of hematologic malignancies and the emergence of newer and more sophisticated therapeutic approaches such as…”
    Get full text
    Journal Article
  7. 7
  8. 8

    CD96 as a Potential Immune Regulator in Cancers by Feng, Shikai, Isayev, Orkhan, Werner, Jens, Bazhin, Alexandr V

    “…The discovery of CTLA-4 and PD-1 checkpoints has prompted scientific researchers and the pharmaceutical industry to develop and conduct extensive research on…”
    Get full text
    Journal Article
  9. 9

    PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia by Soltani, Mojdeh, Ghanadian, Mustafa, Ghezelbash, Behrooz, Shokouhi, Abolfazl, Zamyatnin, Jr, Andrey A, Bazhin, Alexandr V, Ganjalikhani-Hakemi, Mazdak

    Published in BMC cancer (16-05-2023)
    “…Leukemic cell metabolism plays significant roles in their proliferation and survival. These metabolic adaptations are under regulation by different factors…”
    Get full text
    Journal Article
  10. 10

    The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives by Wu, Yang, Zhang, Chun, Jiang, Kuirong, Werner, Jens, Bazhin, Alexandr V, D'Haese, Jan G

    Published in Frontiers in oncology (14-01-2021)
    “…Pancreatic ductal adenocarcinoma (PDAC) is a gastrointestinal malignancy with a dismal clinical outcome. Accumulating evidence suggests that activated…”
    Get full text
    Journal Article
  11. 11

    Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting by Baldin, Alexey V, Savvateeva, Lyudmila V, Bazhin, Alexandr V, Zamyatnin, Jr, Andrey A

    Published in Cancers (05-03-2020)
    “…Dendritic cells (DCs) have shown great potential as a component or target in the landscape of cancer immunotherapy. Different in vivo and ex vivo strategies of…”
    Get full text
    Journal Article
  12. 12

    TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1 by Shapourian, Hooriyeh, Ghanadian, Mustafa, Eskandari, Nahid, Shokouhi, Abolfazl, Demirel, Gülderen Yanikkaya, Bazhin, Alexandr V, Ganjalikhani-Hakemi, Mazdak

    Published in BMC cancer (24-01-2024)
    “…T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a cell surface molecule that was first discovered on T cells. However, recent studies revealed…”
    Get full text
    Journal Article
  13. 13

    Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease by Bazhin, Alexandr V., Strippoli, Raffaele, Sánchez-Álvarez, Miguel, Cordani, Marco, Donadelli, Massimo

    Published in Oxidative medicine and cellular longevity (01-01-2019)
    “…Reactive oxygen species (ROS) and autophagy are two highly complex and interrelated components of cell physiopathology, but our understanding of their…”
    Get full text
    Journal Article
  14. 14

    Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation by Yang, Yuhui, Li, Chunyan, Liu, Tao, Dai, Xiaofang, Bazhin, Alexandr V

    Published in Frontiers in immunology (22-07-2020)
    “…Among the various immunological and non-immunological tumor-promoting activities of myeloid-derived suppressor cells (MDSCs), their immunosuppressive capacity…”
    Get full text
    Journal Article
  15. 15

    The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy? by Ganjalikhani Hakemi, Mazdak, Jafarinia, Morteza, Azizi, Mahdieh, Rezaeepoor, Mahsa, Isayev, Orkhan, Bazhin, Alexandr V

    Published in Frontiers in oncology (03-12-2020)
    “…One of the most common tumors in the world is hepatocellular carcinoma (HCC), and its mortality rates are still on the rise, so addressing it is considered an…”
    Get full text
    Journal Article
  16. 16

    Myeloid-Derived Suppressor Cells in Solid Tumors by Ma, Tianmiao, Renz, Bernhard W, Ilmer, Matthias, Koch, Dominik, Yang, Yuhui, Werner, Jens, Bazhin, Alexandr V

    Published in Cells (Basel, Switzerland) (17-01-2022)
    “…Myeloid-derived suppressor cells (MDSCs) are one of the main suppressive cell population of the immune system. They play a pivotal role in the establishment of…”
    Get full text
    Journal Article
  17. 17

    The Sabotaging Role of Myeloid Cells in Anti‐Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia by Li, Chunyan, Liu, Tao, Bazhin, Alexandr V., Yang, Yuhui

    Published in Journal of cellular physiology (01-09-2017)
    “…Tumor angiogenesis has become a promising target for anti‐tumor therapy. Unfortunately, the somewhat inevitable occurrence of resistance has limited the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy by Bazhin, Alexandr V., Shevchenko, Ivan, Umansky, Viktor, Werner, Jens, Karakhanova, Svetlana

    Published in Cancer Immunology, Immunotherapy (01-01-2014)
    “…Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human neoplasms, having extremely poor prognosis with a 5-year survival rate of <1 % and…”
    Get full text
    Journal Article
  20. 20